Transcainide

This classification denotes an antiarrhythmic agent with the molecular formula C22H35N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 5VSP2X37QG, chemically known as 4-piperidinecarboxamide, 4-(dimethylamino)-n-(2,6-dimethylphenyl)-1-(2-hydroxycyclohexyl)-, trans-(+-)- but more generally known as transcainide, which bears US NIH Compound Identifier 68608. European Medicines Agency schedules Transcainide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11216MIG. The term TRANSCAINIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 38, No. 6, 1984, List 24). TRANSCAINIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule transcainide under HS 29333999 and SITC 51574. As of Q4 2014, TRANSCAINIDE remains US FDA's Preferred Term for this commodity. Transcainide bears US NLM identifiers UMLS ID C0076902 and NCI Concept Code C90667. SMILES: OC1C(N2CCC(N(C)C)(CC2)C(=O)NC2C(CCCC2C)C)CCCC1.